Real-time index price for TSX American Preferred Stock Index (STNC), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

AST SpaceMobile has been on a tear in 2025, but extensive runway remains as this satellite cellular phone technology company ramps up its commercialization efforts. Archer Aviation remains a top ...

In the not-too-distant past, you would be hard-pressed to find any technology company that paid a dividend. But in the modern market, many of the more mature tech companies have begun focusing more on ...

Wall Street made some of its biggest calls of the year in 2025, and not all of them went the same direction. In this video, MarketBeat analyst Thomas Hughes breaks down the five most downgraded stocks ...

My 2025 picks outperformed the S&P 500 by 9.4% and Nasdaq 100 by 5.9%, validating my growth-value approach. Each stock on this list is operating in a different market segment and two are based in ...

These companies offer big-time payouts in today's low-yielding environment. Dividend yields have been steadily declining over the years as many companies have de-emphasized paying dividends. The ...

As traders enter the final trading week of the year, one familiar question dominates Wall Street chatter: Will the Santa Claus Rally show up again? • Newmont stock is trading near recent highs. What ...

Space stocks are soaring into 2026, driven by a potential SpaceX IPO and an executive order signed by President Donald Trump. Investors will likely start looking for undervalued space stocks, ...

For some background on this monthly publication, here is my view on dividend growth stocks: Dividend growth stocks aren't always the most exciting investments out there. They often aren't grabbing the ...

Looking to improve your fashion drawing skills? These 5 tutorials are the best way to master drawing clothes—whether you're starting from scratch or looking to level up your technique! #DrawingClothes ...

William Blair has hand-picked its top five stock recommendations for 2026, selections that include three clinical-stage biotechs in the bunch. The analysts’ selections for the upcoming year span ...